HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon

Table 4 Prevalence of HIV-1 drug resistance among non-CRF02_AG

Resistance Category	No. sequences	Percentage with DRM	1 DRM	2 DRMs	3 DRMs	≥4 DRMs
PI/r	37	2.7%	0	0	0	1
NRTI	37	75.7%	7	6	5	10
NNRTI	37	83.8%	19	10	2	0

ISSN: 1471-2334